Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Short term Debt (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Short term Debt data on record, last reported at $5.4 million in Q4 2025.

  • For Q4 2025, Short term Debt changed 0.0% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $5.4 million, changed 0.0%, while the annual FY2025 figure was $5.4 million, 0.0% changed from the prior year.
  • Short term Debt reached $5.4 million in Q4 2025 per MRVI's latest filing, roughly flat from $5.4 million in the prior quarter.
  • Across five years, Short term Debt topped out at $34.8 million in Q4 2021 and bottomed at $1.3 million in Q3 2021.
  • Average Short term Debt over 5 years is $6.9 million, with a median of $5.4 million recorded in 2022.
  • Peak YoY movement for Short term Debt: surged 480.63% in 2021, then tumbled 84.38% in 2022.
  • A 5-year view of Short term Debt shows it stood at $34.8 million in 2021, then crashed by 84.38% to $5.4 million in 2022, then changed by 0.0% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $5.4 million in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q1 2025.